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In developed countries about 10% of the hospitaliza-
tions are complicated by a healthcare-associated infection
[1]. Up to 75% of these infections are due to multidrug-
resistant organisms (MDROs) [1]. Antimicrobial resistant
bacterial infections are associated to higher morbidity,
mortality and healthcare costs than those caused by sus-
ceptible organisms [1]. The findings of the point preva-
lence survey in European acute care hospitals published in
2013 by the European Centre for Disease Control and Pre-
vention (ECDC) show large variations between countries
and between different regions of the same country, with
Italy being allocated within the high-endemic areas for
both MRSA and MDROs [2].
Despite antimicrobial resistance affects most bacterial
species, MDR Gram negatives represent the most serious
threat. In a few years Enterobacteriaceae, mainly Escheri-
chia coli and Klebsiella pneumoniae, have evolved from
extended spectrum b-lactamase (ESBL) producing to car-
bapanem-resistant organisms [3]. Simultaneously, Acineto-
bacter baumannii has quickly become extremely or pan-
drug resistant [4]. Carbapenem resistant Gram negatives
heavily impact on clinical outcomes with mortality rates
significantly higher than the susceptible strains of the
same species [1]. Of further concern, very few antimicro-
bial agents are available for an effective treatment of these
infections and new agents active against these organisms
are not currently in development.
Many intertwining factors are driving these epidemiolo-
gical changes, involving patients, healthcare delivery sys-
tems, infection control practices and, most important,
misuse and inappropriate use of antibiotics in all health-
care facilities, in community and in animal husbandry. In
particular, the transition of the healthcare delivery systems
from a hospital-centered model to a healthcare facility net-
work has gradually blurred the borders between hospital
and community and the patients’ travel within this net-
work has critically contributed to disseminate MDROs [5].
As a consequence, antimicrobial resistance is now as com-
mon, if not more so, in post-acute clinical facilities, such
as long term care settings and nursing homes [5]. The
“revolving door” is the very efficacious image used as the
paradygm of the spreading routes of organisms with hos-
pital and community reservoirs, as E. coli or MRSA. The
revolving door, indeed, enlightens how the colonized
patients entering back and forth several healthcare settings
drive the amplification of the antibiotic resistance [6].
Stringent infection control and prevention practices
and wise use of antibiotics are unanimously agreed as the
key actions to fight MDROs. Of course, we need new
antibiotics, but first we have to learn how to protect
them from a precipitous erosion of their effectiveness.
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